Aroa Biosurgery has completed the bookbuild for its initial public offering, raising A$45m at a A$225m (NZ$240m) valuation.

READ MORE:
High-tech wound-care company Aroa releases first product in own backyard
Kiwi med-tech Volpara buying

Advertisement
Advertisement